tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Plus Therapeutics upgraded to Buy from Hold at D. Boral Capital
PremiumThe FlyPlus Therapeutics upgraded to Buy from Hold at D. Boral Capital
23d ago
Plus Therapeutics regains compliance with applicable Nasdaq listing criteria
Premium
The Fly
Plus Therapeutics regains compliance with applicable Nasdaq listing criteria
1M ago
Plus Therapeutics Secures Nasdaq Compliance Extension
Premium
Company Announcements
Plus Therapeutics Secures Nasdaq Compliance Extension
1M ago
Buy Rating for Plus Therapeutics: Strategic Market Launch and Promising Financial Outlook
PremiumRatingsBuy Rating for Plus Therapeutics: Strategic Market Launch and Promising Financial Outlook
1M ago
Plus Therapeutics Reports Strong Q2 2025 Results
Premium
Company Announcements
Plus Therapeutics Reports Strong Q2 2025 Results
1M ago
Plus Therapeutics Awaits Nasdaq Compliance Confirmation
Premium
Company Announcements
Plus Therapeutics Awaits Nasdaq Compliance Confirmation
1M ago
Plus Therapeutics’ Innovative Study on Rhenium-186 NanoLiposome for Cancer Metastases
PremiumCompany AnnouncementsPlus Therapeutics’ Innovative Study on Rhenium-186 NanoLiposome for Cancer Metastases
2M ago
Plus Therapeutics says CNSide CSF platform will be available for Texas in August
Premium
The Fly
Plus Therapeutics says CNSide CSF platform will be available for Texas in August
2M ago
Plus Therapeutics announces $1.6M advance payment from CPRIT
Premium
The Fly
Plus Therapeutics announces $1.6M advance payment from CPRIT
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100